Mass spectrometry (MS)-based proteomics and the sulfome: clinical potential
High throughput MS-based proteomics has proven invaluable for the discovery of PTMs, advancing understanding of their roles in human health and disease. With recent advances in strategies for the characterization of protein sulfation, the field is now ready for exploration in a clinical context.
Authors
- Patrick A. Eyers (ORCID: https://orcid.org/0000-0002-9220-2966)
- Daniel J. Rigden (ORCID: https://orcid.org/0000-0002-7565-8937)
- Claire E. Eyers (ORCID: https://orcid.org/0000-0002-3223-5926)
- Sara Jones (ORCID: https://orcid.org/0000-0003-4789-4948)
- Leonard A. Daly (ORCID: https://orcid.org/0000-0001-9712-9676)
- Shahram Mesdaghi (ORCID: https://orcid.org/0009-0009-8328-5972)
- Sally O. Oswald (ORCID: https://orcid.org/0009-0002-1307-4482)
Institutions
- University of Liverpool (GB)
Publication Details
- Journal
- Expert Review of Proteomics
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1080/14789450.2025.2601523
- Primary Topic
- Advanced Proteomics Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00